Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.36 --0%
Financial Fact:
Net Revenues Total: 180.2M
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Net Revenues Total: 180.2M
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter came in at $500.1 million versus the consensus estimate of $470.53 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Marex Group PLC (MRX) PT Raised to $90 at Keefe, Bruyette & Woods
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
